Abstract

The Mulibrey (Muscle–liver–brain–eye) nanism caused by loss-of-function variants in TRIM37 gene is an autosomal recessive disorder characterized by severe growth failure and constrictive pericarditis. These patients also suffer from severe respiratory infections, co-incident with an increased mortality rate. Here, we revealed that TRIM37 variants were associated with recurrent infection. Trim37 FINmajor (a representative variant of Mulibrey nanism patients) and Trim37 knockout mice were susceptible to influenza virus infection. These mice showed defects in follicular helper T (TFH) cell development and antibody production. The effects of Trim37 on TFH cell differentiation relied on its E3 ligase activity catalyzing the K27/29-linked polyubiquitination of Bcl6 and its MATH domain-mediated interactions with Bcl6, thereby protecting Bcl6 from proteasome-mediated degradation. Collectively, these findings highlight the importance of the Trim37-Bcl6 axis in controlling the development of TFH cells and the production of high-affinity antibodies, and further unveil the immunologic mechanism underlying recurrent respiratory infection in Mulibrey nanism.

Details

Title
The TRIM37 variants in Mulibrey nanism patients paralyze follicular helper T cell differentiation
Author
Gu, Wangpeng 1 ; Zhang, Jia 2 ; Li, Qing 2   VIAFID ORCID Logo  ; Zhang, Yaguang 2   VIAFID ORCID Logo  ; Lin, Xuan 3 ; Wu, Bingbing 4 ; Yin, Qi 2 ; Sun, Jinqiao 5 ; Lu, Yulan 4   VIAFID ORCID Logo  ; Sun, Xiaoyu 2 ; Jia, Caiwei 2 ; Li, Chuanyin 2 ; Zhang, Yu 6 ; Wang, Meng 6 ; Yin, Xidi 2 ; Wang, Su 1 ; Xu, Jiefang 1 ; Wang, Ran 1 ; Zhu, Songling 1 ; Cheng, Shipeng 2 ; Chen, Shuangfeng 2 ; Liu, Lian 2 ; Zhu, Lin 2 ; Yan, Chenghua 2 ; Yi, Chunyan 2 ; Li, Xuezhen 2 ; Lian, Qiaoshi 2 ; Lin, Guomei 2 ; Ling, Zhiyang 2 ; Ma, Liyan 2 ; Zhou, Min 7 ; Xiao, Kuanlin 7 ; Wei, Haiming 8 ; Hu, Ronggui 2 ; Zhou, Wenhao 9   VIAFID ORCID Logo  ; Ye, Lilin 10   VIAFID ORCID Logo  ; Wang, Haikun 6   VIAFID ORCID Logo  ; Li, Jinsong 2   VIAFID ORCID Logo  ; Sun, Bing 2 

 University of Science and Technology of China, Division of Life Sciences and Medicine, Hefei, China (GRID:grid.59053.3a) (ISNI:0000000121679639); Chinese Academy of Sciences, University of Chinese Academy of Sciences, State Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Shanghai, China (GRID:grid.410726.6) (ISNI:0000 0004 1797 8419) 
 Chinese Academy of Sciences, University of Chinese Academy of Sciences, State Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Shanghai, China (GRID:grid.410726.6) (ISNI:0000 0004 1797 8419) 
 Institute of Pasteur of Shanghai, Shanghai, China (GRID:grid.429007.8) (ISNI:0000 0004 0627 2381); Shanghai Tech University, School of Life Science and Technology, Shanghai, China (GRID:grid.440637.2) (ISNI:0000 0004 4657 8879) 
 Children’s Hospital of Fudan University, National Children’s Medical Center, Center for Molecular Medicine, Shanghai, China (GRID:grid.411333.7) (ISNI:0000 0004 0407 2968) 
 Children’s Hospital of Fudan University, National Children’s Medical Center, Department of Allergy and Clinical Immunology, Shanghai, China (GRID:grid.411333.7) (ISNI:0000 0004 0407 2968) 
 Institute of Pasteur of Shanghai, Shanghai, China (GRID:grid.429007.8) (ISNI:0000 0004 0627 2381) 
 Eye and ENT Hospital of Fudan University, Department of Ophthalmology, Shanghai, China (GRID:grid.411079.a) (ISNI:0000 0004 1757 8722) 
 University of Science and Technology of China, Division of Life Sciences and Medicine, Hefei, China (GRID:grid.59053.3a) (ISNI:0000000121679639) 
 Children’s Hospital of Fudan University, National Children’s Medical Center, Center for Molecular Medicine, Shanghai, China (GRID:grid.411333.7) (ISNI:0000 0004 0407 2968); Children’s Hospital of Fudan University, National Children’s Medical Center, Department of Neonatology, Shanghai, China (GRID:grid.411333.7) (ISNI:0000 0004 0407 2968) 
10  Third Military Medical University, Institute of Immunology, Chongqing, China (GRID:grid.410570.7) (ISNI:0000 0004 1760 6682); Beijing Changping Laboratory, Beijing, China (GRID:grid.410570.7) 
Pages
82
Publication year
2023
Publication date
2023
Publisher
Springer Nature B.V.
e-ISSN
20565968
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2844438994
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.